More likely- FDA gave approval- Silviu had a few tears and went to roll out the product.
Then the FDA wanted vials distributed according to patient weight AFTER APPROVAL- Post approval labelling/marketing requirements.
Approval was for 1 vial or 4 vials with a code for each.
After approval, that changed- so the supply chain needed altering from Singapore to the US distribution Centers- Paperwork would have needed to be updated at every treatment centre- packaging changed- contents of packaging even down to swabs per box. ALL new changes.
How thrilled Silviu and the team must have been.
Now when a patient requires treatment they may order for example a box of 4 and a box of two- 6 vials in total - they are anticipated to arrive at most of the major centres in around 24 hours.
The vials have been ready since approval- the packaging supply chain was altered- launch is imminent.
More than a hunch- it is based on the recent release of new codes and package volumes.
Why the change- now I will have my hunch- they,the FDA, want to curb a blackmarket in our cells and future maufacturers cells. Excess is supposed to be destroyed- yeah right- at $200,000 a vial - woops I dropped it, yes I flushed it crushed it and stuffed it up my scrubs.
I am as certain as I can be that the company will announce multiple dosings day 1- the queue must be backed up, unless we have been providing stock under the EAP.
You go Silviu- most of your detractors couldn't spell mesemqimole.
Reg
MSB Price at posting:
$2.04 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)